A Toronto couple is down to two options to get a dose of a $2.8-million gene therapy that could potentially save their baby’s life: either raise the money themselves and buy it in the U.S. or win a dose in an international lottery run by the Swiss drugmaker.

This entry was posted on Tuesday, December 31st, 2019 at 7:14 am and is filed under Finance/ Money. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.